Previously uncharacterized “orphan” RNA molecules can serve as highly specific, blood-detectable barcodes of cancer identity and, in some cases, act as previously unrecognized oncogenic drivers.
In a study in Cell Reports Medicine, scientists conducted a large-scale analysis of RNA sequencing data across multiple tumor types to catalog transcripts that are not part of standard gene annotations. These orphan RNAs were found to be selectively activated in cancer cells and largely absent from normal adult tissues, creating tumor-specific expression patterns.
Notably, many of these transcripts were detectable in blood-derived RNA, indicating that they are accessible through liquid biopsy approaches. Because orphan RNAs showed strong tissue and tumor-type specificity, they functioned as molecular barcodes capable of distinguishing cancer types based on circulating nucleic acids. This specificity suggests potential utility in refining cancer classification when tissue of origin is uncertain, such as in cancers of unknown primary.
Beyond their role as markers, a subset of orphan RNAs demonstrated features consistent with functional relevance in cancer biology. The study identified examples in which these transcripts were associated with tumor growth and regulatory pathways, supporting the concept that some orphan RNAs may represent cancer-emergent oncogenic drivers rather than passive byproducts of dysregulated transcription.
The findings expand the landscape of potential RNA biomarkers beyond conventional protein-coding genes and well-characterized noncoding RNAs. Current liquid biopsy assays typically focus on DNA mutations or established RNA targets. Incorporating systematically annotated orphan RNAs could enhance assay sensitivity and specificity, particularly for early detection or minimal residual disease monitoring.
Further studies will be needed to establish the potential of orphan RNAs to reveal cancer-subtype signatures and relationships to treatment response. The researchers conclude with the hope that orphan RNAs will prove to be invaluable tools in the understanding and treatment of cancer.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
